Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cytokinetics Inc (CYTK)

  • Company Report
  • Oct. 20, 2022, 22:30 UTC
  • 36

Cytokinetics to Announce Third Quarter Results on November 3, 2022

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Oct. 17, 2022, 14:11 UTC
  • 31

Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022

Comment Full text

Abcam Plc (ABCM)

  • Company Report
  • Oct. 17, 2022, 00:14 UTC
  • 32

Abcam Plc Notification

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Oct. 14, 2022, 04:12 UTC
  • 33

New Form 3 for Quantum-Si Incorporated

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Oct. 14, 2022, 04:11 UTC
  • 35

Quantum-Si’s Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research

Comment Full text

Relmada Therapeutics Inc (RLMD)

  • Company Report
  • Oct. 14, 2022, 04:11 UTC
  • 35

Relmada Therapeutics Announces Top-line Results from Phase 3 RELIANCE III Trial for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder

Comment Full text

Supernus Pharmaceuticals Inc (SUPN)

  • Company Report
  • Oct. 12, 2022, 07:33 UTC
  • 38

New Form 8-K for Supernus Pharmaceuticals

Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Company Report
  • Oct. 10, 2022, 13:46 UTC
  • 35

Rigel Provides Update on Plans for sNDA for wAIHA Program Following FDA Feedback

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Oct. 10, 2022, 10:06 UTC
  • 38

New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX)

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Oct. 10, 2022, 10:06 UTC
  • 34

New SEC Filing for (CIK:0001061027)

Comment Full text
  • Previous
  • 57
  • 58
  • 59
  • 60
  • 61
  • Next

Search

News categories

  • Technical Exchange News(9342)
  • Event(407)
  • SEC News(152288)
  • FDA Approval(8709)
  • Company Report(721)
  • Business News(104139)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin